StockNews.AI
OM
StockNews.AI
197 days

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

1. Outset Medical will report Q4 and full-year 2024 results on February 19, 2025. 2. CEO Leslie Trigg and CFO Nabeel Ahmed will discuss financial performance during a call. 3. Outset's Tablo® system simplifies dialysis, enhancing patient care and operational efficiency.

4m saved
Insight
Article

FAQ

Why Bullish?

Upcoming financial results could indicate growth, similar to positive trends seen in previous quarters.

How important is it?

The earnings report may significantly influence stock price due to potential positive news.

Why Short Term?

Immediate financial results will affect investor sentiment and stock performance soon after release.

Related Companies

OM
February 03, 2025 09:00 ET  | Source: Outset Medical, Inc. SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2024 after the close of trading on Wednesday, February 19, 2025. On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results. Conference Call DetailsThe conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, February 19, 2025. Those interested in joining the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/. About Outset Medical, Inc.Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc. ContactJim Mazzola Investor Relations jmazzola@outsetmedical.com

Related News